药物设计与发现 1119条(本栏目收费,不能显示细节,电话13136136841)
physical properties, 124 124
short-lived and long-lived isotopes, 124 124
selectivity and Bmax, 123 123
tracer principle, 123 123
butyrylcholinesterase catalyzed hydrolysis,169–170 170
clopidogrel and prasugrel, 167–168 168
HepDirect®-prodrugs, 168–169 169
improved formulation and administration,161–162 162
improved passive permeability, 163–165 165
improved transporter-mediated permeability,165–166 165–166
prolonged duration, 170 170
site-specific bioactivation, 166 166
tumor-selective activation pathway, 167 167
chemical derivatives, 155–156 156
clinical use, 156–157 157
discovery and development 0
regulatory aspects, 172–173 173
safety evaluation, 172 172
functional groups, 158–159 159
Protein biosynthesis, 421–425 425
30S ribosomal subunit inhibitors, 421 421